Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	708.88	-1033.81	127.81
Graham Fair Price	36.21	3.20	2.35
PEG	-86.13	0.11	-0.80
Price/Book	10.08	0.93	0.84
Price/Cash Flow	inf	0.00	73.58
Prices/Earnings	-21.16	6.64	8.43
Price/Sales	7.65	9.08	8.43
Price/FCF	inf	0.00	73.58
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.59	0.96	1.00
Operating Margin	346290.92	0.54	< 0.005
ROA	48.56	< 0.005	< 0.005
ROE	0.03	0.03	39.61
ROIC	< 0.005	0.02	460728.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.39	-0.05	-634.08
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.00	3643.00	364330.29
EPS QOQ	-0.11	0.60	468.56
FCF QOQ	-0.09	-1.00	-1048.57
Revenue QOQ	< 0.005	0.05	469.61
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	7.25	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.67	0.46	-31.62
Quick Ratio	-1.95	1.08	-44.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.13	3.60	15.28
Cash	-4.36	2.80	-35.79
Capex	0.00	0.00	0.00
Free Cash Flow	0.04	0.00	inf
Revenue	0.31	0.37	17.88
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.97	1.09	-44.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-18.95	-92.88	-390.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating